1. Home
  2. JBDI vs ADIL Comparison

JBDI vs ADIL Comparison

Compare JBDI & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JBDI Holdings Limited Ordinary Shares

JBDI

JBDI Holdings Limited Ordinary Shares

N/A

Current Price

$2.36

Market Cap

9.5M

Sector

N/A

ML Signal

N/A

Logo Adial Pharmaceuticals Inc

ADIL

Adial Pharmaceuticals Inc

SELL

Current Price

$5.05

Market Cap

10.2M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
JBDI
ADIL
Founded
1983
2010
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.5M
10.2M
IPO Year
2023
2017

Fundamental Metrics

Financial Performance
Metric
JBDI
ADIL
Price
$2.36
$5.05
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
★ $8.33
AVG Volume (30 Days)
★ 4.4M
31.6K
Earning Date
10-15-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.39
$0.13
52 Week High
$9.50
$8.75

Technical Indicators

Market Signals
Indicator
JBDI
ADIL
Relative Strength Index (RSI) 58.81 62.80
Support Level $0.79 $3.80
Resistance Level $9.50 $6.26
Average True Range (ATR) 0.93 0.45
MACD -0.01 0.15
Stochastic Oscillator 4.79 95.35

Price Performance

Historical Comparison
JBDI
ADIL

About JBDI JBDI Holdings Limited Ordinary Shares

JBDI Holdings Ltd, through its subsidiaries, is mainly engaged in the reconditioning and recycling of containers in Singapore. Its products include reconditioned and new steel drums, plastic drums, carboys, and IBCs with different capacities, and its customers span various industries such as the solvent, chemical, petroleum, and edible oil industries. Additionally, the Group offers ancillary services, such as reconditioning services, wastewater equipment services, and sales of recycled materials and services to complement its core business. The majority of its revenue is derived from the sale of reconditioned containers. Geographically, the Group derives all its revenue from Singapore.

About ADIL Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.

Share on Social Networks: